Developing vaccines and antibodies for dangerous RNA viruses
Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
This study is working on new vaccines and treatments to help protect people from serious illnesses caused by certain viruses, aiming to improve prevention and care for those affected by these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10862496 on NIH RePORTER |
What this research studies
This research focuses on creating vaccines and therapeutic antibodies to combat emerging and reemerging RNA viruses that pose significant threats to public health. It specifically targets viruses from the Paramyxoviridae and Bunyavirales families, which are known to cause severe diseases such as hemorrhagic fevers. The approach involves studying these viruses and their interactions with the immune system to develop effective countermeasures. Patients may benefit from advancements in prevention and treatment options for these viral infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk of exposure to these high-priority viral pathogens, such as healthcare workers and those living in endemic regions.
Not a fit: Patients with viral infections not related to the targeted pathogens may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines and treatments for severe viral infections that currently have no approved therapies.
How similar studies have performed: Previous research has shown promise in developing vaccines and therapies for similar viral pathogens, indicating a potential for success in this area.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Geisbert, Thomas William — University of Texas Med Br Galveston
- Study coordinator: Geisbert, Thomas William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.